NOVEMBER 2024

Actions on our screens

 

EUCERIN COMBINES 3D AND CGI AT EPIGENETIC SERUM LAUNCH IN CALLAO CITY LIGHTS

 

On the occasion of the launch of its new Hyaluron-Filler Epigenetic Serum with Epicelline, Eucerin has launched a spectacular campaign on the screens of Callao City Lights that combines 3D with simulated outdoor advertising (CGI- Computer Generated Imagery). An innovative action in line with this revolutionary anti-ageing product that visibly reverses the signs of ageing and reactivates the skin’s youth genes.

The 3D campaign shows a woman’s face pointing to one of her cheeks, one of the areas where the effects of Hyaluron-Filler Epigenetic Serum can be seen, which then appears on screen. This is the moment when the 3D effect of this piece can be seen, giving the impression that the product protrudes from the support.

In the CGI, the actress Belén Cuesta, who poses looking at the camera in the middle of Callao square, grabs the product that seems to emerge from the Callao screen and puts it in her handbag. After which, she seeks the viewer’s complicity by winking at them.

The 3D and CGI work was conceived and developed by Maramura Experiences and the media management was handled by OMD.

‘This Eucerin campaign is a great example of the exceptional results that the combination of 3D and CGI technology linked to screens offers in outdoor advertising. A formula that contributes to enhance the actions carried out in DOOH, for its spectacularity and possibilities of viralisation in social networks’, says Gorka Pagazazaurtundua, commercial director of Callao City Lights.

Other events in Callao City Lights

Other actions in Callao City Lights

POKÉMON INVASION IN CALLAO SQUARE

POKÉMON INVASION IN CALLAO SQUARE

NOVEMBER 2024 Actions on our screens  POKÉMON INVASION IN CALLAO SQUARE  On the occasion of the arrival of the Pokémon Gigamax in the Pokémon Go video game, the brand held a special event in...

Don't miss anything!

Don't miss anything!

Subscribe to our newsletter and you will be kept up to date with our news.

Thank you for subscribing!

Share This